Our study demonstrates that ovarian cancer cells with PRKCI amplification undergo apoptosis at a higher rate when PKCι is silenced, indicating that PRKCI amplification is a critical factor driving ovary tumorigenesis and such cells are thus addicted to PKCι function. The gene discussed is PRKCI; the disease is ovarian cancer.